Growth Metrics

Oruka Therapeutics (ORKA) Shareholder's Equity Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Oruka Therapeutics 3.04 Bn 2.65 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 33.45%
Dec 31, 2025 23.47%
Sep 30, 2025 42.18%
Jun 30, 2025 1,285.75%
Mar 31, 2025 5,266.81%
Dec 31, 2024 932.47%
Sep 30, 2024 801.73%
Jun 30, 2024 -173.86%
Mar 31, 2024 -117.42%
Dec 31, 2023 -11.17%
Sep 30, 2023 -11.14%
Jun 30, 2023 -12.73%
Mar 31, 2023 -15.45%
Dec 31, 2022 -18.36%
Sep 30, 2022 -24.51%
Jun 30, 2022 -26.54%
Mar 31, 2022 -27.27%
Dec 31, 2021 9.72%
Sep 30, 2021 12.18%
Jun 30, 2021 493.96%
Mar 31, 2021 945.18%
Dec 31, 2020 511.31%
Sep 30, 2020 473.42%
Jun 30, 2020 12.14%
Mar 31, 2020 -13.83%
Dec 31, 2019 26.16%
Sep 30, 2019 17.90%
Jun 30, 2019 2.12%
Mar 31, 2019 -33.80%
Dec 31, 2018 -41.29%
Sep 30, 2018 -48.00%
Jun 30, 2018 -38.98%
Mar 31, 2018 -38.71%
Dec 31, 2017 -53.70%
Sep 30, 2017 -45.80%
Jun 30, 2017 -52.26%
Mar 31, 2017 -47.85%
Dec 31, 2016 -41.70%
Sep 30, 2016 -35.56%
Jun 30, 2016 -29.40%
Mar 31, 2016 185.18%
Dec 31, 2015 158.26%
Sep 30, 2015 138.94%
Jun 30, 2015 126.48%
Mar 31, 2015 -43.68%
Dec 31, 2014 -5.39%
Sep 30, 2014 -6.37%
Jun 30, 2014 -3.55%
Mar 31, 2014 550.38%
Dec 31, 2013 435.98%
Sep 30, 2013 478.37%
Jun 30, 2013 509.46%
Mar 31, 2013 -23.99%
Dec 31, 2012 -49.28%
Sep 30, 2012 -44.59%
Jun 30, 2012 -56.43%
Dec 31, 2011 -15.34%